Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

22.52 +0.56 (+2.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results
From Schrödinger
Via Business Wire
Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion
Hansoh announced a $1.3 billion deal to develop three siRNA candidates from London's Silence Therapeutics. In the past week, Hansoh also revealed a $456 million deal with Korea's OliX Pharma for China... 
Via Talk Markets
Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists
From Schrödinger, Inc.
Via Business Wire
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Recap: Schrodinger Q2 Earnings
Shares of Schrodinger (NASDAQ:SDGR) decreased 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 880.00% over... 
Via Benzinga
Healthcare Cloud Computing Market Size Is Set To Surpass USD $79 Billion By 2027
Palm Beach, FL – October 21, 2021 – FinancialNewsMedia.com News Commentary – The growing awareness pertaining to healthcare cloud computing has uplifted the market growth positively in developed... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Bet On Biopharma: Data, Digitization, Discovery
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the... 
Via Talk Markets
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
A key gene-editing readout had Cathie Wood shuffling her portfolio. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021
Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ: 
Via Benzinga
MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program
From Schrödinger, Inc.
Via Business Wire
This Healthcare Company Is Using AI to Develop Drugs
Could this technology be the future of the pharmaceutical industry? 
Via The Motley Fool
Topics Artificial Intelligence Cannabis
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Present at Four Investor Conferences in September
From Schrödinger
Via Business Wire
Why Schrödinger Shares Are Rising
Schrödinger Inc (NASDAQ: SDGR) shares are trading higher by 4.8% at $62.58 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced an $82... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
Upgrades For Chatham Lodging Trust (NYSE: 
Via Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrodinger, inc (SDGR) Q2 2021 Earnings Call Transcript
SDGR earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Schrödinger Stock Is Trading Lower After Reporting Deeper Than Expected Q2 Loss
Schrödinger Inc (NASDAQ: SDGR) has reported Q2 revenues of $29.78 million, +29% Y/Y, slightly missing the consensus of $29.88 million. Software revenue was $... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million.... 
Via Benzinga
Schrödinger Reports Second Quarter 2021 Financial Results and Provides Company Update
From Schrödinger, Inc.
Via Business Wire
Week In Review: China Life Science Posts $1.3 Billion In Deals
Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a... 
Via Talk Markets
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... 
Via Benzinga
Schrödinger, Zai Lab Team Up For Cancer Program Targeting DNA Damage Response
Schrödinger Inc (NASDAQ: SDGR) and Zai Lab Limited (NASDAQ: ZLAB) have collaborated to discover, develop, and commercialize oncology candidate ... 
Via Benzinga
Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology
From Zai Lab Limited
Via Business Wire
Schrödinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results
From Schrödinger, Inc.
Via Business Wire
Schrödinger Hosts First Annual Educator’s Day and Announces “Teaching with Schrödinger” Program
From Schrödinger, Inc.
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Present at Two Virtual Investor Conferences in July
From Schrödinger
Via Business Wire
The 1 Stock I'd Buy Right Now
I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that. 
Via The Motley Fool
My Favorite Biotech Stock Right Now
I'm an owner of Schrodinger because this company's software is revolutionizing drug discovery, and it's going to be a monster stock over the next decade. 
Via The Motley Fool
Topics Cannabis
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.